Inventor
NARGUND RAVI
US36 patents
⚠️ This page may combine multiple inventors who share the name “NARGUND RAVI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK SHARP & DOHME
16 patentsUS9364482B2Jun 14, 2016
Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
MERCK SHARP & DOHME8 citations84
US10183981B2Jan 22, 2019
Insulin receptor partial agonists
MERCK SHARP & DOHME5 citations83
US9243002B2Jan 26, 2016
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
MERCK SHARP & DOHME8 citations83
US10793615B2Oct 6, 2020
Long-acting co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME4 citations72
US10413593B2Sep 17, 2019
Co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME2 citations72
US10017556B2Jul 10, 2018
Insulin receptor partial agonists
MERCK SHARP & DOHME3 citations72
US11041009B2Jun 22, 2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
MERCK SHARP & DOHME2 citations71
US9932311B2Apr 3, 2018
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME4 citations71
US11492385B2Nov 8, 2022
Long-acting co-agonists of the glucagon and GLP-1 receptors
MERCK SHARP & DOHME1 citations61
US10689430B2Jun 23, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME1 citations61
US11058775B2Jul 13, 2021
Insulin dimer-incretin conjugates
MERCK SHARP & DOHME0 citations52
US11034661B2Jun 15, 2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
MERCK SHARP & DOHME0 citations51
US10800827B2Oct 13, 2020
Insulin receptor partial agonists
MERCK SHARP & DOHME0 citations51
US8354394B2Jan 15, 2013
Diuretics
MERCK SHARP & DOHME0 citations51
US9809568B2Nov 7, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations50
US9493461B2Nov 15, 2016
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
MERCK SHARP & DOHME0 citations40
MERCK & CO INC
15 patentsUS5721251AFeb 24, 1998
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC75 citations95
US5767118AJun 16, 1998
4-Heterocyclic peperidines promote release of growth hormone
MERCK & CO INC36 citations93
US5656606AAug 12, 1997
Camphor compounds promote release of growth hormone
MERCK & CO INC30 citations93
US6121325ASep 19, 2000
Naphthyl compounds promote release of growth hormone
MERCK & CO INC33 citations92
US6063796AMay 16, 2000
Somatostatin agonists
MERCK & CO INC38 citations92
US5965565AOct 12, 1999
Piperidines promote release of growth hormone
MERCK & CO INC30 citations92
US5880125AMar 9, 1999
4-spiroindoline piperidines promote release of growth hormone
MERCK & CO INC35 citations92
US5804578ASep 8, 1998
Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC57 citations92
US5663171ASep 2, 1997
Acyclic compounds promote release of growth hormone
MERCK & CO INC45 citations92
US5559128ASep 24, 1996
3-substituted piperidines promote release of growth hormone
MERCK & CO INC51 citations92
US5492920AFeb 20, 1996
Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
MERCK & CO INC53 citations92
US5877182AMar 2, 1999
Piperidines promote release of growth hormone
MERCK & CO INC49 citations91
US5925659AJul 20, 1999
Antibacterial agents
MERCK & CO INC38 citations90
US5830433ANov 3, 1998
Radiolabeled growth hormone secretagogue
MERCK & CO INC26 citations89
US5777112AJul 7, 1998
Piperazine compounds promote release of growth hormone
MERCK & CO INC13 citations68